Atrial fibrillation information


Anticoagulation risk assessment


From ACC/AHA/ESC 2006 guidelines: JACC 2006;48:854-906

High risk factors Moderate risk factors Weaker risk factors
Previous stroke, TIA, or embolism
Mitral stenosis
Prosthetic valve (INR >2.5)
Age ≥ 75
Hypertension
Heart failure
LVEF < 35%
Diabetes
Female gender
Age 65 - 74
Coronary artery disease
Thyrotoxicosis
Risk category Recommended therapy
No risk factors Aspirin, 81 - 325 mg qd
1 moderate risk factor Aspirin, 81 - 325 mg qd - or -
warfarin
>1 moderate risk factor or any high risk factor warfarin